|
| 37868041 | Equity, diversity, and inclusion at the Global Alliance for Genomics and Health. | Cell Genom | 2023 |
| 32487065 | Effects of an mHealth voice message service (mMitra) on maternal health knowledge and practices of low-income women in India: findings from a pseudo-randomized controlled trial. | BMC Public Health | 2020 |
| 30900262 | The continuing saga of patents and non-invasive prenatal testing. | Prenat Diagn | 2019 |
| 31584144 | The Impact of an mHealth Voice Message Service (mMitra) on Infant Care Knowledge, and Practices Among Low-Income Women in India: Findings from a Pseudo-Randomized Controlled Trial. | Matern Child Health J | 2019 |
| 31436165 | The Elusive Path Toward Measuring Health Outcomes: Lessons Learned From a Pseudo-Randomized Controlled Trial of a Large-Scale Mobile Health Initiative. | JMIR Mhealth Uhealth | 2019 |
| 27277130 | "The Top Priority Is a Healthy Baby": Narratives of Health, Disability, and Abortion in Online Pregnancy Forum Discussions in the US and China. | J Genet Couns | 2017 |
| 28301696 | Toward an Ethically Sensitive Implementation of Noninvasive Prenatal Screening in the Global Context. | Hastings Cent Rep | 2017 |
| 28298412 | Emerging Considerations for Noninvasive Prenatal Testing. | Clin Chem | 2017 |
| 27244688 | Impact of the increased adoption of prenatal cfDNA screening on non-profit patient advocacy organizations in the United States. | Prenat Diagn | 2016 |
| 27668172 | Barriers to clinical adoption of next generation sequencing: Perspectives of a policy Delphi panel. | Appl Transl Genom | 2016 |
| 28002697 | Sequenom v. Ariosa - The Death of a Genetic Testing Patent. | N Engl J Med | 2016 |
| 25790161 | Too much, too soon?: Commercial provision of noninvasive prenatal screening for subchromosomal abnormalities and beyond. | Genet Med | 2015 |
| 26322648 | Noninvasive Prenatal Genetic Testing: Current and Emerging Ethical, Legal, and Social Issues. | Annu Rev Genomics Hum Genet | 2015 |
| 26368398 | Intellectual property rights and challenges for development of affordable human papillomavirus, rotavirus and pneumococcal vaccines: Patent landscaping and perspectives of developing country vaccine manufacturers. | Vaccine | 2015 |
| 26085345 | Global perspectives on clinical adoption of NIPT. | Prenat Diagn | 2015 |
| 25653560 | Non-invasive prenatal testing: a review of international implementation and challenges. | Int J Womens Health | 2015 |
| 24718856 | Noninvasive prenatal testing goes global. | Sci Transl Med | 2014 |
| 25687341 | Preliminary perspectives on DNA collection in anti-human trafficking efforts. | Recent Adv DNA Gene Seq | 2014 |
| 25298290 | Patents and genome-wide DNA sequence analysis: is it safe to go into the human genome? | J Law Med Ethics | 2014 |
| 24989832 | Do recent US Supreme Court rulings on patenting of genes and genetic diagnostics affect the practice of genetic screening and diagnosis in prenatal and reproductive care? | Prenat Diagn | 2014 |
| 23534337 | Harm, hype and evidence: ELSI research and policy guidance. | Genome Med | 2013 |
| 24231943 | Cystic Fibrosis Patents: A Case Study of Successful Licensing. | LES Nouv | 2013 |
| 23686656 | Commercial landscape of noninvasive prenatal testing in the United States. | Prenat Diagn | 2013 |
| 20393305 | Impact of gene patents and licensing practices on access to genetic testing for inherited susceptibility to cancer: comparing breast and ovarian cancers with colon cancers. | Genet Med | 2010 |
| 20697400 | DNA patents and diagnostics: not a pretty picture. | Nat Biotechnol | 2010 |
| 20622834 | Intellectual property, technology transfer and manufacture of low-cost HPV vaccines in India. | Nat Biotechnol | 2010 |
| 20393313 | Spinocerebellar ataxia: patient and health professional perspectives on whether and how patents affect access to clinical genetic testing. | Genet Med | 2010 |
| 20393311 | Impact of gene patents and licensing practices on access to genetic testing and carrier screening for Tay-Sachs and Canavan disease. | Genet Med | 2010 |
| 20393308 | Impact of gene patents and licensing practices on access to genetic testing for cystic fibrosis. | Genet Med | 2010 |
| 20393306 | Impact of gene patents and licensing practices on access to genetic testing for hereditary hemochromatosis. | Genet Med | 2010 |
| 20393307 | Impact of gene patents and licensing practices on access to genetic testing for hearing loss. | Genet Med | 2010 |
| 20393304 | Impact of gene patents and licensing practices on access to genetic testing for long QT syndrome. | Genet Med | 2010 |
| 19010439 | Microsomal prostaglandin E synthase-2 is not essential for in vivo prostaglandin E2 biosynthesis. | Prostaglandins Other Lipid Mediat | 2009 |
| 19804612 | Gene patents and personalized medicine - what lies ahead? | Genome Med | 2009 |
| 19325608 | The dangers of diagnostic monopolies. | Nature | 2009 |
| 19204690 | Proprietary science, open science and the role of patent disclosure: the case of zinc-finger proteins. | Nat Biotechnol | 2009 |
| 17493263 | Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. | Genome Biol | 2007 |
| 16204198 | Coupling of COX-1 to mPGES1 for prostaglandin E2 biosynthesis in the murine mammary gland. | J Lipid Res | 2005 |
| 15186217 | The tyrosine kinase FRK/RAK participates in cytokine-induced islet cell cytotoxicity. | Biochem J | 2004 |
| 12077350 | Characterization of mice deficient in the Src family nonreceptor tyrosine kinase Frk/rak. | Mol Cell Biol | 2002 |
| 7592908 | Transforming growth factor beta activates the promoter of cyclin-dependent kinase inhibitor p15INK4B through an Sp1 consensus site. | J Biol Chem | 1995 |